Submitted by Anonymous (not verified) on 22 October 2024 - 15:02
Orphan designation: Atrasentan Treatment of primary IgA nephropathy, 10/12/2021 Positive
Source:
Orphan designation: Atrasentan Treatment of primary IgA nephropathy, 10/12/2021 Positive